B2M and melanoma: While loss of beta-2 microglobulin, a membrane protein component of the MHC class I has been associated with acquired resistance to anti-PD1 blockade in melanoma,41 upregulation of other genes in the antigen processing pathway may alter the neoantigen landscapes that results in immune evasion.